{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:48:11Z","timestamp":1794383291812,"version":"4.9.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Transferrable mechanisms of quinolone resistance (TMQR) can lead to fluoroquinolone non-susceptibility in addition to chromosomal mechanisms. Some evidence suggests that fluoroquinolone resistance is increasing among the pediatric population. We sought to determine the occurrence of TMQR genes among quinolone-resistant <jats:italic>E. coli<\/jats:italic> and <jats:italic>K. pneumoniae<\/jats:italic> causing urinary tract infections among Nepalese outpatient children (&lt;\u200918 years) and identify molecular characteristics of TMQR-harboring isolates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed antimicrobial susceptibility testing, phenotypic extended-spectrum \u03b2-lactamase (ESBL) and modified carbapenem inactivation method tests, and investigated the presence of six TMQR genes (<jats:italic>qnrA<\/jats:italic>, <jats:italic>qnrB<\/jats:italic>, <jats:italic>qnrS<\/jats:italic>, <jats:italic>aac(6\u2019)-Ib-cr<\/jats:italic>, <jats:italic>oqxAB, qepA<\/jats:italic>), three ESBL genes (<jats:italic>bla<\/jats:italic><jats:sub>CTX\u2212M<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>TEM<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>SHV<\/jats:sub>), and five carbapenemase genes (<jats:italic>bla<\/jats:italic><jats:sub>NDM<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>OXA\u221248<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>KPC<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>IMP<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>VIM<\/jats:sub>). The quinolone resistance-determining region (QRDR) of <jats:italic>gyrA<\/jats:italic> and <jats:italic>parC<\/jats:italic> were sequenced for 35 TMQR-positive isolates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 74\/147 (50.3%) isolates were TMQR positive by multiplex PCR [<jats:italic>aac(6\u2019)-Ib-cr<\/jats:italic> in 48 (32.7%), <jats:italic>qnrB<\/jats:italic> in 23 (15.7%), <jats:italic>qnrS<\/jats:italic> in 18 (12.3%), <jats:italic>qnrA<\/jats:italic> in 1 (0.7%), and <jats:italic>oqxAB<\/jats:italic> in 1 (0.7%) isolate]. The median ciprofloxacin minimum inhibitory concentration of TMQR-positive isolates (64\u00a0\u00b5g\/mL) was two-fold higher than those without TMQR (32\u00a0\u00b5g\/mL) (p\u2009=\u20090.004). Ser-83\u2192Leu and Asp-87\u2192Asn in GyrA and Ser-80\u2192Ile in ParC were the most common QRDR mutations (23 of 35). In addition, there was a statistically significant association between TMQR and two \u03b2-lactamase genes; <jats:italic>bla<\/jats:italic><jats:sub>CTX\u2212M<\/jats:sub> (p\u2009=\u20090.037) and <jats:italic>bla<\/jats:italic><jats:sub>TEM<\/jats:sub> (p\u2009=\u20090.000).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study suggests a high prevalence of TMQR among the quinolone-resistant <jats:italic>E. coli<\/jats:italic> and <jats:italic>K. pneumoniae<\/jats:italic> isolates causing urinary tract infection in children in this area of Nepal and an association with the carriage of ESBL gene. This is a challenge for the management of urinary infections in children. Comprehensive prospective surveillance of antimicrobial resistance in these common pathogens will be necessary to devise strategies to mitigate the emergence of further resistance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-023-04279-5","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T10:01:38Z","timestamp":1694599298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Characterization of Transferrable Mechanisms of Quinolone Resistance (TMQR) among Quinolone-resistant Escherichia coli and Klebsiella pneumoniae causing Urinary Tract Infection in Nepalese Children"],"prefix":"10.1186","volume":"23","author":[{"given":"Raj Kumar","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashmita","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruba","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabi","family":"Pokhrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubhav","family":"Aryal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupika","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipun","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhim Gopal","family":"Dhoubhadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"issue":"9","key":"4279_CR1","doi-asserted-by":"publisher","first-page":"a025320","DOI":"10.1101\/cshperspect.a025320","volume":"6","author":"DC Hooper","year":"2016","unstructured":"Hooper DC, Jacoby GA. Topoisomerase inhibitors: Fluoroquinolone Mechanisms of Action and Resistance. Cold Spring Harb Perspect Med. 2016;6(9):a025320. https:\/\/doi.org\/10.1101\/cshperspect.a025320.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"4279_CR2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3947\/ic.2014.46.4.226","volume":"46","author":"ES Kim","year":"2014","unstructured":"Kim ES, Hooper DC. Clinical importance and epidemiology of Quinolone Resistance. Infect Chemother. 2014;46(4):226\u201338. https:\/\/doi.org\/10.3947\/ic.2014.46.4.226.","journal-title":"Infect Chemother"},{"key":"4279_CR3","unstructured":"World Health Organization Model List of Essential Medicines \u2013 22nd List., 2021. Geneva: World Health Organization; 2021 (WHO\/MHP\/HPS\/EML\/2021.02). Licence: CC BY-NC-SA 3.0 IGO. https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2021.02."},{"key":"4279_CR4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1186\/s12879-015-1282-4","volume":"15","author":"O Fasugba","year":"2015","unstructured":"Fasugba O, Gardner A, Mitchell BG, Mnatzaganian G. Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies. BMC Infect Dis. 2015;15:545. https:\/\/doi.org\/10.1186\/s12879-015-1282-4.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"4279_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5173\/ceju.2021.0053","volume":"74","author":"A Ong","year":"2021","unstructured":"Ong A, Mahobia N, Browning D, Schembri M, Somani BK. Trends in antibiotic resistance for over 700,000 Escherichia coli positive urinary tract infections over six years (2014\u20132019) from a university teaching hospital. Cent Eur J Urol. 2021;74(2):249\u201354. https:\/\/doi.org\/10.5173\/ceju.2021.0053.","journal-title":"Cent Eur J Urol"},{"issue":"5","key":"4279_CR6","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1017\/ice.2018.26","volume":"39","author":"MJ Durkin","year":"2018","unstructured":"Durkin MJ, Jafarzadeh SR, Hsueh K, Sallah YH, Munshi KD, Henderson RR, et al. Outpatient antibiotic prescription Trends in the United States: A National Cohort Study. Infect Control Hosp Epidemiol. 2018;39(5):584\u20139. https:\/\/doi.org\/10.1017\/ice.2018.26.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"4279_CR7","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1093\/jac\/dkw345","volume":"71","author":"DA Williamson","year":"2016","unstructured":"Williamson DA, Roos R, Verrall A, Smith A, Thomas MG. Trends, demographics and disparities in outpatient antibiotic consumption in New Zealand: a national study. J Antimicrob Chemother. 2016;71(12):3593\u20138. https:\/\/doi.org\/10.1093\/jac\/dkw345.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"4279_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2174\/156802609789630947","volume":"9","author":"K Drlica","year":"2009","unstructured":"Drlica K, Hiasa H, Kerns R, Malik M, Mustaev A, Zhao X. Quinolones: action and resistance updated. Curr Top Med Chem. 2009;9(11):981\u201398. https:\/\/doi.org\/10.2174\/156802609789630947.","journal-title":"Curr Top Med Chem"},{"issue":"5","key":"4279_CR9","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/jac\/dkg222","volume":"51","author":"J Ruiz","year":"2003","unstructured":"Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother. 2003;51(5):1109\u201317. https:\/\/doi.org\/10.1093\/jac\/dkg222.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"4279_CR10","doi-asserted-by":"publisher","first-page":"e00007","DOI":"10.1128\/CMR.00007-19","volume":"32","author":"J Ruiz","year":"2019","unstructured":"Ruiz J. Transferable mechanisms of Quinolone Resistance from 1998 onward. Clin Microbiol Rev. 2019;32(4):e00007\u201319. https:\/\/doi.org\/10.1128\/CMR.00007-19.","journal-title":"Clin Microbiol Rev"},{"key":"4279_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.drup.2016.09.001","volume":"29","author":"JM Rodr\u00edguez-Mart\u00ednez","year":"2016","unstructured":"Rodr\u00edguez-Mart\u00ednez JM, Machuca J, Cano ME, Calvo J, Mart\u00ednez-Mart\u00ednez L, Pascual A. Plasmid-mediated quinolone resistance: two decades on. Drug Resist Updat. 2016;29:13\u201329. https:\/\/doi.org\/10.1016\/j.drup.2016.09.001.","journal-title":"Drug Resist Updat"},{"issue":"4","key":"4279_CR12","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1517\/14740338.4.4.623","volume":"4","author":"RW Grady","year":"2005","unstructured":"Grady RW. Systemic quinolone antibiotics in children: a review of the use and safety. Expert Opin Drug Saf. 2005;4(4):623\u201330. https:\/\/doi.org\/10.1517\/14740338.4.4.623.","journal-title":"Expert Opin Drug Saf"},{"key":"4279_CR13","doi-asserted-by":"publisher","first-page":"i939","DOI":"10.1136\/bmj.i939","volume":"352","author":"A Bryce","year":"2016","unstructured":"Bryce A, Hay AD, Lane IF, Thornton HV, Wootton M, Costelloe C. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. BMJ. 2016;352:i939. https:\/\/doi.org\/10.1136\/bmj.i939.","journal-title":"BMJ"},{"issue":"3","key":"4279_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ajur.2020.05.008","volume":"8","author":"AR Nateghian","year":"2021","unstructured":"Nateghian AR, Karaji S, Zamani K. A decade of trends in the distribution and antimicrobial susceptibility of prevalent uropathogens among pediatric patients from Tehran, Iran during 2005\u20132016. Asian J Urol. 2021;8(3):253\u20139. https:\/\/doi.org\/10.1016\/j.ajur.2020.05.008.","journal-title":"Asian J Urol"},{"key":"4279_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s41182-020-00251-6","volume":"48","author":"GB Raya","year":"2020","unstructured":"Raya GB, Dhoubhadel BG, Shrestha D, Raya S, Laghu U, Shah A, et al. Multidrug-resistant and extended-spectrum beta-lactamase-producing uropathogens in children in Bhaktapur, Nepal. Trop Med Health. 2020;48:65. https:\/\/doi.org\/10.1186\/s41182-020-00251-6.","journal-title":"Trop Med Health"},{"key":"4279_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13756-016-0168-6","volume":"6","author":"NP Parajuli","year":"2017","unstructured":"Parajuli NP, Maharjan P, Parajuli H, Joshi G, Paudel D, Sayami S, et al. High rates of multidrug resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal. Antimicrob Resist Infect Control. 2017;6:9. https:\/\/doi.org\/10.1186\/s13756-016-0168-6.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"4279_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12887-019-1410-1","volume":"19","author":"LB Shrestha","year":"2019","unstructured":"Shrestha LB, Baral R, Poudel P, Khanal B. Clinical, etiological and antimicrobial susceptibility profile of pediatric urinary tract infections in a tertiary care hospital of Nepal. BMC Pediatr. 2019;19(1):36. https:\/\/doi.org\/10.1186\/s12887-019-1410-1.","journal-title":"BMC Pediatr"},{"issue":"1","key":"4279_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13104-019-4875-y","volume":"13","author":"J Thapaliya","year":"2020","unstructured":"Thapaliya J, Khadka P, Thapa S, Gongal C. Enhanced quantitative urine culture technique, a slight modification, in detecting under-diagnosed pediatric urinary tract infection. BMC Res Notes. 2020;13(1):5. https:\/\/doi.org\/10.1186\/s13104-019-4875-y.","journal-title":"BMC Res Notes"},{"key":"4279_CR19","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, Thirty first Informational Supplement in M100-S30, Wayne. PA., USA; 2020."},{"key":"4279_CR20","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically Document in M07-A9, 10th Edn. Wayne, PA., USA; 2015."},{"issue":"3","key":"4279_CR21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"4279_CR22","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1128\/AAC.00576-07","volume":"51","author":"JS Lewis","year":"2007","unstructured":"Lewis JS, Herrera M, Wickes B, Patterson JE, Jorgensen JH. First Report of the emergence of CTX-M-Type extended-spectrum \u03b2-Lactamases (ESBLs) as the predominant ESBL isolated in a U.S. Health Care System. Antimicrob Agents Chemother. 2007;51(11):4015\u201321. https:\/\/doi.org\/10.1128\/AAC.00576-07.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"4279_CR23","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/jac\/dkp498","volume":"65","author":"C Dallenne","year":"2010","unstructured":"Dallenne C, Da Costa A, Decr\u00e9 D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important \u03b2-lactamases in Enterobacteriaceae. J Antimicrob Chemother. 2010;65(3):490\u20135. https:\/\/doi.org\/10.1093\/jac\/dkp498.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"4279_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","volume":"70","author":"L Poirel","year":"2011","unstructured":"Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119\u2013. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2010.12.002. https:\/\/doi.org\/https:\/\/doi.org\/. 23.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Pt 12","key":"4279_CR25","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1099\/jmm.0.064428-0","volume":"62","author":"H Ciesielczuk","year":"2013","unstructured":"Ciesielczuk H, Hornsey M, Choi V, Woodford N, Wareham DW. Development and evaluation of a multiplex PCR for eight plasmid-mediated quinolone-resistance determinants. J Med Microbiol. 2013;62(Pt 12):1823\u20137. https:\/\/doi.org\/10.1099\/jmm.0.064428-0.","journal-title":"J Med Microbiol"},{"issue":"10","key":"4279_CR26","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1128\/AAC.42.10.2661","volume":"42","author":"LM Weigel","year":"1998","unstructured":"Weigel LM, Steward CD, Tenover FC. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob Agents Chemother. 1998;42(10):2661\u20137. https:\/\/doi.org\/10.1128\/AAC.42.10.2661.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"4279_CR27","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1128\/AAC.40.2.491","volume":"40","author":"J Vila","year":"1996","unstructured":"Vila J, Ruiz J, Go\u00f1i P, De Anta MT. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother. 1996;40(2):491\u20133. https:\/\/doi.org\/10.1128\/AAC.40.2.491.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4279_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/jac\/dks365","volume":"68","author":"S Paltansing","year":"2012","unstructured":"Paltansing S, Kraakman MEM, Ras JMC, Wessels E, Bernards AT. Characterization of fluoroquinolone and cephalosporin resistance mechanisms in Enterobacteriaceae isolated in a dutch teaching hospital reveals the presence of an Escherichia coli ST131 clone with a specific mutation in parE. J Antimicrob Chemother. 2012;68(1):40\u20135. https:\/\/doi.org\/10.1093\/jac\/dks365.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"4279_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3947\/ic.2020.52.2.194","volume":"52","author":"B Kim","year":"2020","unstructured":"Kim B, Seo M-R, Kim J, Kim Y, Wie S-H, Ki M, et al. Molecular epidemiology of ciprofloxacin-resistant Escherichia coli isolated from community-acquired urinary tract infections in Korea. Infect Chemother. 2020;52(2):194\u2013203. https:\/\/doi.org\/10.3947\/ic.2020.52.2.194.","journal-title":"Infect Chemother"},{"key":"4279_CR30","doi-asserted-by":"publisher","first-page":"32281","DOI":"10.1038\/srep32281","volume":"6","author":"C-Y Kao","year":"2016","unstructured":"Kao C-Y, Wu H-M, Lin W-H, Tseng C-C, Yan J-J, Wang M-C, et al. Plasmid-mediated quinolone resistance determinants in quinolone-resistant Escherichia coli isolated from patients with bacteremia in a university hospital in Taiwan, 2001\u20132015. Sci Rep. 2016;6:32281. https:\/\/doi.org\/10.1038\/srep32281.","journal-title":"Sci Rep"},{"issue":"3","key":"4279_CR31","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1128\/JCM.02594-14","volume":"53","author":"L Zhao","year":"2015","unstructured":"Zhao L, Zhang J, Zheng B, Wei Z, Shen P, Li S, et al. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese County Hospitals. J Clin Microbiol. 2015;53(3):766\u201370. https:\/\/doi.org\/10.1128\/JCM.02594-14.","journal-title":"J Clin Microbiol"},{"key":"4279_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jgar.2018.11.003","volume":"17","author":"R Azargun","year":"2019","unstructured":"Azargun R, Soroush Barhaghi MH, Samadi Kafil H, Ahangar Oskouee M, Sadeghi V, Memar MY, et al. Frequency of DNA gyrase and topoisomerase IV mutations and plasmid-mediated quinolone resistance genes among Escherichia coli and Klebsiella pneumoniae isolated from urinary tract infections in Azerbaijan, Iran. J Glob Antimicrob Resist. 2019;17:39\u201343. https:\/\/doi.org\/10.1016\/j.jgar.2018.11.003.","journal-title":"J Glob Antimicrob Resist"},{"issue":"6","key":"4279_CR33","doi-asserted-by":"publisher","first-page":"e0178888","DOI":"10.1371\/journal.pone.0178888","volume":"12","author":"J Osei Sekyere","year":"2017","unstructured":"Osei Sekyere J, Amoako DG. Genomic and phenotypic characterisation of fluoroquinolone resistance mechanisms in Enterobacteriaceae in Durban, South Africa. PLoS ONE. 2017;12(6):e0178888. https:\/\/doi.org\/10.1371\/journal.pone.0178888.","journal-title":"PLoS ONE"},{"issue":"1","key":"4279_CR34","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1186\/s12879-019-4606-y","volume":"19","author":"DN Kotb","year":"2019","unstructured":"Kotb DN, Mahdy WK, Mahmoud MS, Khairy RMM. Impact of co-existence of PMQR genes and QRDR mutations on fluoroquinolones resistance in Enterobacteriaceae strains isolated from community and hospital acquired UTIs. BMC Infect Dis. 2019;19(1):979. https:\/\/doi.org\/10.1186\/s12879-019-4606-y.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"4279_CR35","doi-asserted-by":"publisher","first-page":"e02146","DOI":"10.1128\/AAC.02146-21","volume":"66","author":"M-D Phan","year":"2022","unstructured":"Phan M-D, Peters KM, Fraga LA, Wallis SC, Hancock SJ, Nhu NTK, et al. Plasmid-mediated Ciprofloxacin Resistance imparts a selective advantage on Escherichia coli ST131. Antimicrob Agents Chemother. 2022;66(1):e02146\u201321. https:\/\/doi.org\/10.1128\/AAC.02146-21.","journal-title":"Antimicrob Agents Chemother"},{"key":"4279_CR36","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.2147\/idr.S160720","volume":"11","author":"R Azargun","year":"2018","unstructured":"Azargun R, Sadeghi MR, Soroush Barhaghi MH, Samadi Kafil H, Yeganeh F, Ahangar Oskouee M, et al. The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections. Infect Drug Resist. 2018;11:1007\u201314. https:\/\/doi.org\/10.2147\/idr.S160720.","journal-title":"Infect Drug Resist"},{"issue":"2","key":"4279_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.7883\/yoken.66.151","volume":"66","author":"NH Kim","year":"2013","unstructured":"Kim NH, Choi EH, Sung JY, Oh CE, Kim HB, Kim E-C, et al. Prevalence of plasmid-mediated Quinolone Resistance genes and Ciprofloxacin Resistance in Pediatric Bloodstream isolates of Enterobacteriaceae over a 9-Year period. Jpn J Infect Dis. 2013;66(2):151\u20134. https:\/\/doi.org\/10.7883\/yoken.66.151.","journal-title":"Jpn J Infect Dis"},{"issue":"8","key":"4279_CR38","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1099\/jmm.0.000551","volume":"66","author":"BF Ara\u00fajo","year":"2017","unstructured":"Ara\u00fajo BF, Campos PAd, Royer S, Ferreira ML, Gon\u00e7alves IR, Batist\u00e3o DWdF, et al. High frequency of the combined presence of QRDR mutations and PMQR determinants in multidrug-resistant Klebsiella pneumoniae and Escherichia coli isolates from nosocomial and community-acquired infections. J Med Microbiol. 2017;66(8):1144\u201350. https:\/\/doi.org\/10.1099\/jmm.0.000551.","journal-title":"J Med Microbiol"},{"issue":"1","key":"4279_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1089\/mdr.2016.0004","volume":"23","author":"G Xue","year":"2016","unstructured":"Xue G, Li J, Feng Y, Xu W, Li S, Yan C, et al. High prevalence of plasmid-mediated Quinolone Resistance Determinants in Escherichia coli and Klebsiella pneumoniae isolates from Pediatric Patients in China. Microb Drug Resist. 2016;23(1):107\u201314. https:\/\/doi.org\/10.1089\/mdr.2016.0004.","journal-title":"Microb Drug Resist"},{"issue":"11","key":"4279_CR40","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1089\/mdr.2020.0007","volume":"26","author":"M Akgoz","year":"2020","unstructured":"Akgoz M, Akman I, Ates AB, Celik C, Keskin B, Ozmen Capin BB, et al. Plasmidic Fluoroquinolone Resistance genes in fluoroquinolone-resistant and\/or extended Spectrum Beta-Lactamase-Producing Escherichia coli strains isolated from Pediatric and adult patients diagnosed with urinary tract infection. Microb Drug Resist. 2020;26(11):1334\u201341. https:\/\/doi.org\/10.1089\/mdr.2020.0007.","journal-title":"Microb Drug Resist"},{"issue":"7","key":"4279_CR41","doi-asserted-by":"publisher","first-page":"e0254805","DOI":"10.1371\/journal.pone.0254805","volume":"16","author":"A Zemmour","year":"2021","unstructured":"Zemmour A, Dali-Yahia R, Maatallah M, Saidi-Ouahrani N, Rahmani B, Benhamouche N, et al. High-risk clones of extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae isolated from the University Hospital establishment of Oran, Algeria (2011\u20132012). PLoS ONE. 2021;16(7):e0254805. https:\/\/doi.org\/10.1371\/journal.pone.0254805.","journal-title":"PLoS ONE"},{"issue":"6","key":"4279_CR42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/INF.0000000000002205","volume":"38","author":"LK Logan","year":"2019","unstructured":"Logan LK, Medernach RL, Rispens JR, Marshall SH, Hujer AM, Domitrovic TN, et al. Community Origins and Regional differences highlight risk of plasmid-mediated Fluoroquinolone resistant Enterobacteriaceae infections in children. Pediatr Infect Dis J. 2019;38(6):595\u20139. https:\/\/doi.org\/10.1097\/INF.0000000000002205.","journal-title":"Pediatr Infect Dis J"},{"key":"4279_CR43","unstructured":"Global antimicrobial resistance and use surveillance system (GLASS) report. 2022. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO. https:\/\/www.who.int\/publications\/i\/item\/9789240062702."},{"issue":"1","key":"4279_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12941-020-00390-y","volume":"19","author":"S Manandhar","year":"2020","unstructured":"Manandhar S, Zellweger RM, Maharjan N, Dongol S, Prajapati KG, Thwaites G, et al. A high prevalence of multi-drug resistant gram-negative bacilli in a Nepali tertiary care hospital and associated widespread distribution of extended-spectrum beta-lactamase (ESBL) and carbapenemase-encoding genes. Ann Clin Microbiol Antimicrob. 2020;19(1):48. https:\/\/doi.org\/10.1186\/s12941-020-00390-y.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"8","key":"4279_CR45","doi-asserted-by":"publisher","first-page":"e42919","DOI":"10.1371\/journal.pone.0042919","volume":"7","author":"LTM Vien","year":"2012","unstructured":"Vien LTM, Minh NNQ, Thuong TC, Khuong HD, Nga TVT, Thompson C, et al. The Co-Selection of Fluoroquinolone Resistance genes in the Gut Flora of Vietnamese Children. PLoS ONE. 2012;7(8):e42919. https:\/\/doi.org\/10.1371\/journal.pone.0042919.","journal-title":"PLoS ONE"},{"issue":"4","key":"4279_CR46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1099\/jmm.0.000686","volume":"67","author":"R Saksena","year":"2018","unstructured":"Saksena R, Gaind R, Sinha A, Kothari C, Chellani H, Deb M. High prevalence of fluoroquinolone resistance amongst commensal flora of antibiotic na\u00efve neonates: a study from India. J Med Microbiol. 2018;67(4):481\u20138. https:\/\/doi.org\/10.1099\/jmm.0.000686.","journal-title":"J Med Microbiol"},{"issue":"4","key":"4279_CR47","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3343\/alm.2018.38.4.384","volume":"38","author":"B Li","year":"2018","unstructured":"Li B, Chen Y, Wu Z, Zhao Z, Wu J, Cao Y. Prevalence of plasmid-mediated Quinolone Resistance genes among Escherichia coli in the gut of healthy people in Fuzhou, China. Ann Lab Med. 2018;38(4):384\u20136. https:\/\/doi.org\/10.3343\/alm.2018.38.4.384.","journal-title":"Ann Lab Med"},{"issue":"Pt 12","key":"4279_CR48","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1099\/jmm.0.010033-0","volume":"58","author":"LT Minh Vien","year":"2009","unstructured":"Minh Vien LT, Baker S, Phuong Thao LT, Phuong Tu LT, Thu Thuy C, Thu Nga TT, et al. High prevalence of plasmid-mediated quinolone resistance determinants in commensal members of the Enterobacteriaceae in Ho Chi Minh City, Vietnam. J Med Microbiol. 2009;58(Pt 12):1585\u201392. https:\/\/doi.org\/10.1099\/jmm.0.010033-0.","journal-title":"J Med Microbiol"},{"issue":"1","key":"4279_CR49","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.1038\/s41467-019-13467-w","volume":"10","author":"M Magruder","year":"2019","unstructured":"Magruder M, Sholi AN, Gong C, Zhang L, Edusei E, Huang J, et al. Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection. Nat Commun. 2019;10(1):5521. https:\/\/doi.org\/10.1038\/s41467-019-13467-w.","journal-title":"Nat Commun"},{"key":"4279_CR50","doi-asserted-by":"publisher","first-page":"617002","DOI":"10.3389\/fcimb.2021.617002","volume":"11","author":"V Perez-Carrasco","year":"2021","unstructured":"Perez-Carrasco V, Soriano-Lerma A, Soriano M, Guti\u00e9rrez-Fern\u00e1ndez J, Garcia-Salcedo JA. Urinary microbiome: Yin and Yang of the urinary tract. Front Cell Infect Microbiol. 2021;11:617002. https:\/\/doi.org\/10.3389\/fcimb.2021.617002.","journal-title":"Front Cell Infect Microbiol"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-023-04279-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-023-04279-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-023-04279-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T16:23:23Z","timestamp":1700497403000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-023-04279-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4279"],"URL":"https:\/\/doi.org\/10.1186\/s12887-023-04279-5","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,13]]},"assertion":[{"value":"22 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the ethical review committee of the Nepal Health Research Council (NHRC) (Reg. no. 100\/2020). The ethics committee of NHRC waived the need for informed consent due to the retrospective nature of this study. The bacterial isolates were obtained as a part of the hospital\u2019s routine patient diagnosis, and the current work was conducted as a part of the hospital\u2019s routine surveillance. Data used in this retrospective study were accessed from microbiology laboratory records which were devoid of any personal identifiers. Thus, individual written informed consent was not applicable and was waived by the ethical review committee of NHRC. All methods were carried out in compliance with National Ethical Guidelines for Health Research in Nepal 2022.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"458"}}